AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06055777 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SZEY-2108 for injetion
Description: Part1（Single-dose intravenous infusion dose-escalation trial）:100mg，200mg，500mg, 1000mg, 2000mg，4000mg and the dose of last cohort to be determined. Single intravenous doses on D1；Part 2（Multi-dose intravenous infusion dose-escalation trial）：1000mg at Q8h，2000mg at Q8h, and one dose level of 1000mg, 1500mg or 2000mg at Q6h. Multiple intravenous doses of SZEY-2108 at Q8h or Q6h on D1\~D7 and on the morning of D8.
Study NCT06055777 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Part1（Single-dose intravenous infusion dose-escalation trial）:250mL/500mL，Single intravenous doses on D1；Part 2（Multi-dose intravenous infusion dose-escalation trial）：250mL,Multiple intravenous doses of placebo at Q8h or Q6h on D1\~D7 and on the morning of D8.
Study NCT05296629 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DFD-29
Description: DFD-29 (40 mg) extended release capsules
Study NCT05296629 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxycycline
Description: Doxycycline 40 mg capsules
Study NCT05296629 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules
Study NCT04990674 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: REMOTION
Description: REMOTION is an internet-based program focusing on emotion regulation and aimed at reducing patient symptom severity and improving emotion regulation. It consists of six modules and the structure is based on the extended process model of emotion regulation by Gross (2015). The intervention is currently being studied in an outpatient psychotherapy setting (Bielinski et al., 2020).
Study NCT04990674 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TAU
Description: Treatment as usual (TAU), refers to standard treatment in an acute inpatient care setting at the Universitäre Psychiatrische Dienste Bern. This treatment includes different standard inpatient psychiatric care components (integrative psychiatric care).
Study NCT04990674 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: Treatment as usual (TAU), refers to standard treatment in an acute inpatient care setting at the Universitäre Psychiatrische Dienste Bern. This treatment includes different standard inpatient psychiatric care components (integrative psychiatric care).
Study NCT05311475 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone
Description: Mometasone furoate nasal spray (50 mcg per actuation)
Study NCT05311475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mometasone
Description: Mometasone furoate nasal spray (50 mcg per actuation)
Study NCT05311475 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azelastine
Description: Azelastine hydrochloride nasal spray (140 mcg per actuation)
Study NCT05311475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azelastine
Description: Azelastine hydrochloride nasal spray (140 mcg per actuation)
Study NCT05152615 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Short Chain Fatty Acids (SCFA) Dietary Supplement
Description: Butryate 1000 mg three times daily will be used in this study.
Study NCT05389241 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Method A
Description: The subjects will perform tasks on the liver phantom (identification of target lesions). They will perform the tasks with Method A (2D-CT) or Method B (2D-CT + 3D augmented reality model). the intervention type Method A means that the trainings set up is performed first with Method A an after that with Method B.
Study NCT05389241 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Method B
Description: The subjects will perform tasks on the liver phantom (identifikation of target lesions). They will perform the tasks with Method A (2D-CT) or Method B (2D-CT + 3D augmented reality model). the intervention type Method B means that the trainings set up is performed first with Method B an after that with Method A.
Study NCT05311475 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo nasal spray
Study NCT05798104 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collaborative nurse-pharmacist counseling
Description: At the interventional appointment, study participants will first complete a modified Okere-Reiner pre-survey assessing patient perceptions of confidence and knowledge in their biologic therapy. Subsequently, a pharmacist will perform a refresher medication counseling, detailing indication, dosing, storage, and side effects. Upon completion of this counseling, an infusion nurse will then provide education demonstrating proper self-administration to the patient. The patient will then self-administer the medication with coaching and direct observation from the nurse. Afterwards, the patient will complete the Okere-Reiner post-survey to determine the effectiveness of the counseling session at improving perceived confidence and knowledge. Patients will complete both the pre-and post-surveys with direct entry to REDCap on an institution iPad during the study intervention visit.
Study NCT04440228 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TeamSTEPPS
Description: TeamSTEPPS is an evidence-based approach for teams that can be adapted for school mental health.~Team Strategies and Tools to Enhance Performance and Patient Safety (TeamSTEPPS), has been widely disseminated in health care settings with promising outcomes. TeamSTEPPS is designed to build competencies in the areas of leadership, situation monitoring, mutual support, and communication and has been associated with improvements in teamwork and communication as well as patient outcomes, such as decreased seclusion in psychiatric hospitals.
Study NCT04074954 — intervention group
Intervention type: PROCEDURE
Intervention: Cataract surgery
Description: Patients will receive cataract surgery
Study NCT06492603 — intervention group
Intervention type: DEVICE
Intervention: Ultrasonography
Description: Ultrasound is an assessment device that uses high-energy sound waves to look at either superficial tissues like linea alba and/or organs inside the body. The sound waves make echoes that form pictures of the tissues and organs on a computer screen (sonogram).
Study NCT06492603 — intervention group
Intervention type: DEVICE
Intervention: The MyotonPRO Device
Description: The MyotonPro is a portable device for measuring biomechanical and viscoelastic properties in superficial soft tissues
Study NCT05079217 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: High-dosage SARS-CoV-2 vaccine
Description: SARS-CoV-2 Inactivated Vaccine 1200SU inactivated virus in 0.5 mL of aluminium hydroxide solution per injection
Study NCT05079217 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Medium-dosage SARS-CoV-2 vaccine
Description: SARS-CoV-2 Inactivated Vaccine 600SU inactivated virus in 0.5 mL of aluminium hydroxide solution per injection
Study NCT04978363 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BOOT
Description: A walking boot is a common type of brace/boot that restricts ankle and foot movement.
Study NCT04978363 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HFC
Description: The Hands Free Crutch (HFC) by iWalkFree, Inc. is a novel, ambulatory assistive device that prevents foot and ankle loading while also allowing free use of the arms and hands.
Study NCT04978363 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAC
Description: Standard axillary crutches (SAC) are ambulatory assistive devices, commonly used for lower extremity injuries or surgeries.
Study NCT04978363 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HFC+BOOT
Description: The Hands Free Crutch (HFC) by iWalkFree, Inc. is a novel, ambulatory assistive device that prevents foot and ankle loading while also allowing free use of the arms and hands. A walking boot is a common type of brace/boot that restricts ankle and foot movement.
Study NCT04978363 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAC+BOOT
Description: Standard axillary crutches (SAC) are ambulatory assistive devices, commonly used for lower extremity injuries or surgeries. A walking boot is a common type of brace/boot that restricts ankle and foot movement.
Study NCT05305040 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Posoleucel (ALVR105)
Description: Administered as 2-4 milliliter infusion, visually identical to placebo
Study NCT06543615 — intervention group
Intervention type: DEVICE
Intervention: Ultrasonography
Description: Ultrasound assessment of residual gastric volume
Study NCT05892653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABM-1310
Description: Dose Escalation Stage: Subjects will be given oral dosing of ABM-1310 twice daily (BID) for 28-day cycles of continuous administration until progressive disease (PD), unacceptable toxicity, or other withdrawal criteria are met as clinically observed.~Dose Expansion Stage: Subjects will begin to receive oral doses of ABM-1310, BID, for 28-day cycles at a fixed dose level (as determined at the dose escalation stage) until PD, unacceptable toxicity, or other withdrawal criteria are met as clinically observed.
Study NCT05305040 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered as 2-4 milliliter infusion, visually identical to Posoleucel (ALVR105)
Study NCT05581134 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality intervention
Description: Virtual reality (VR) is a powerful tool to create an illusory state in which the user can feel that they have been transported to a new location (place illusion), that events happening are real (plausibility illusion), and even that bodies have been substituted by an avatar (embodiment illusion). VR illusions are driven by the same neurological mechanisms of everyday perception of the body in the world and induce realistic responses to VR.
Study NCT05581134 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Group intervention
Description: Treatment will follow general treatment principles in physiotherapy for FMDs: (1) education; (2) exploration of how symptoms affect movement and posture; (3) retraining movement using strategies based on redirection of attention; and (4) development of a self-management plan.
Study NCT05374460 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Explanatory diagram
Description: Participant is told there will be a mismatch between their target finger and the visual indicator of target finger position. They will be shown a diagram explaining this.
Study NCT04624399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Patients receive 2 x 3-weekly cycles of Atezolizumab (one infusion on the first day of each cycle) prior to cystectomy surgery.
Study NCT06356987 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Herniotomy
Description: In Group A Laparoscopic assisted needle herniotomy was done
Study NCT05374460 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Direct vision
Description: Foamboard under mirror removed, making the mirror see-through and the hand directly visible. Mismatch between target hand and visual indicator will be directly visible.
Study NCT05374460 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Movement feedback, target hand
Description: After the participant points at each target, a cursor indicating final pointing position will be displayed briefly. The visual indicator of the target hand will be displaced.
Study NCT06356987 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Herniotomy
Description: In Group A Laparoscopic assisted needle herniotomy was done
Study NCT05374460 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Movement feedback, pointing hand
Description: After the participant points at each target, a cursor indicating final pointing position will be displayed briefly. The visual indicator of the target hand will not change, but the cursor indicating pointing hand position will change.
Study NCT05374460 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: No movement feedback
Description: The visual indicator of the target hand will be displaced, but there will be no cursor to indicate the pointing hand's position.
Study NCT05374460 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Attend to the targets
Description: Participants will not be told anything about the visuo-proprioceptive mismatch. Instead, they will be asked simply to attend to the target positions.
Study NCT04350866 — intervention group
Intervention type: BEHAVIORAL
Intervention: Expert Recommendations for Implementing Change bundle of strategies
Description: * Develop a formal implementation blueprint/checklist~* Conduct educational meetings~* Develop and distribute educational materials~* Organize implementation meetings~* Facilitation~* Increase demand with marketing to patients~* Promote adaptability
Study NCT04350866 — intervention group
Intervention type: BEHAVIORAL
Intervention: Brief Behavioral Treatment for Insomnia
Description: An adapted version of Cognitive Behavioral Therapy for Insomnia (CBT-I) that is focused on behavioral components stimulus control and sleep restriction (the four rules):~1. Reduce time awake in bed.~2. Don't go to bed unless ready for sleep.~3. Don't stay in bed unless asleep.~4. Get up and out of bed at the same time everyday.~Delivered weekly to bi-weekly over 4-6 sessions, with each session typically 30 minutes or less, consistent with other interventions delivered in PCMHI.
Study NCT05015400 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plain Water
Description: To increase water fluid intake, an additional 1.89 L, during phase 1 of the menstrual cycle (days 1-5).
Study NCT06104527 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: Standard protein enteral nutrition with enteral tracer
Description: Enteral nutrition with standard (1.3 g/kg/d) protein provision, given via a nasogastric tube. An oral L-\[1-13C\]-phenylalanine tracer is given as co-intervention. Use of an enterally given tracer is necessary to determine indicator amino acid oxidation.
Study NCT06104527 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: High protein enteral nutrition with enteral tracer
Description: Enteral nutrition with high (2.0 g/kg/d) protein provision, given via a nasogastric tube. An oral L-\[1-13C\]-phenylalanine tracer is given as co-intervention. Use of an enterally given tracer is necessary to determine indicator amino acid oxidation.
Study NCT06221917 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Face-to-face
Description: FTF group are participants who will learn simple sutures physically present with the instructor in the same room.
Study NCT06221917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Live-streaming
Description: One general surgeon (FH) will teach the participants how to do simple sutures on a mannequin, starting by explaining, then doing a live-demo step-by-step of simple wound suturing. The instructor uses a GoPro Hero 8 device on her head which is connected to the internet and produced live-streaming video, which will then be watched by LS group.
Study NCT05962749 — intervention group
Intervention type: OTHER
Intervention: Assessment
Description: 3 meter backward walk test (3MBWT), 10 meter walk test (10MWT), Selective Control Assessment of the Lower Extremities (SCALE), Trunk Control Measurement Scale (TCMS), Pediatric Balance Scale (PBS), Functional Independence Measure for Children (WeeFIM), Modified Ashworth Scale (MAS)
Study NCT06529965 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: covivio
Description: Participants will receive access to the digital health intervention covivio in addition to TAU.
Study NCT05173480 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation
Description: Exercise therapy through conventional rehabilitation training made by physiotherapists.
Study NCT05173480 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation
Description: Exercise therapy through conventional rehabilitation training made by physiotherapists.
Study NCT05173480 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Rehabilitation System (VRRS)
Description: Exercise therapy through a virtual reality rehabilitation system (VRRS).
Study NCT05173480 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Reality Rehabilitation System (VRRS)
Description: Exercise therapy through a virtual reality rehabilitation system (VRRS) with sensors not connected.
Study NCT04591899 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CAD/CAM splints
Description: Each of the maxillary and mandibular cast will scanned alone and then both scanned together in the centric relation using FREEDOM HD scanner1.~The CAD/ CAM splint will be designed using Exocad software; the design will be the same as the conventional one. The surveying will be done by the software and the under-cuts blocked.~The splints will be printed using Dent2 3D printer and then cured using Dentcure. The CAD/CAM splints material will be hard resin from PhotoCentric 3D.
Study NCT04591899 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CAD/CAM splints
Description: Each of the maxillary and mandibular cast will scanned alone and then both scanned together in the centric relation using FREEDOM HD scanner1.~The CAD/ CAM splint will be designed using Exocad software; the design will be the same as the conventional one. The surveying will be done by the software and the under-cuts blocked.~The splints will be printed using Dent2 3D printer and then cured using Dentcure. The CAD/CAM splints material will be hard resin from PhotoCentric 3D.
Study NCT05552378 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Multi-Gyn FloraFem
Description: Vaginal gel packed in 5 single use plastic tubes.
Study NCT05645484 — intervention group
Intervention type: DRUG
Intervention: 18F-PFPN
Description: 18F-PFPN (dose: 3.0-5.4 MBq/kg) will be injected intravenously prior to imaging.
Study NCT05645484 — intervention group
Intervention type: DRUG
Intervention: 18F-FDG
Description: 18F-FDG (dose: 3.7-5.4 MBq/kg) will be injected intravenously prior to imaging.
Study NCT05648760 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simulation training
Description: Participants randomized to the simulation condition received simulation training based on a standard training of how to communicate bad news to patients
Study NCT05648760 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Simulation training
Description: Participants randomized to the simulation condition received simulation training based on a standard training of how to communicate bad news to patients
Study NCT05692193 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: pain education
Description: Pain education was given to the experimental group for 20-30 minutes on the day of hospitalization.
Study NCT06487026 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ArcBlate Focused Ultrasound Ablation System
Description: MR-guided High Intensity Focused Ultrasound (MRgHIFU)
Study NCT05372003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: dupilumab injections will be prescribed and managed by dermatology as standard of care
Study NCT05372003 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Photo therapy
Description: light therapy will be prescribed and managed by dermatology as standard of care
Study NCT06268925 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises
Description: number of exercises will be guided to do through zoom
Study NCT06454292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oliceridine Fumarate
Description: After subjects were enrolled, the original sedative and analgesic drugs were discontinued, and a starting dose of 6ug/kg/h of oliceridine fumarate was continuously pumped, and the time of oliceridine fumarate initiation was recorded as T0. Subjects were assessed for sedation using the RASS score, and for analgesia using the CPOT score. Waiting for the original sedative-analgesic drug to elute until CPOT ≥ 3 and RASS > 0. Adjust the infusion rate of oliceridine fumarate according to the CPOT score (recommended to be adjusted by 2ug/kg/h, the range of adjustment is 2-20 ug /kg/h, and the maximum infusion rate is not more than 20 ug /kg/h) until the analgesic score of the subject is CPOT\<3. The interval between two trial drug rate adjustments should be ≧5 min, and a CPOT score should be performed before each drug adjustment.
Study NCT06454292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: After subjects were enrolled, the original sedative and analgesic drugs were discontinued, and remifentanil was continuously pumped at a starting dose of 1.5ug/kg/h. The time of remifentanil initiation was recorded as T0. Subjects were assessed for sedation using the RASS score and analgesia using the CPOT score. We waited for the original sedative-analgesic drugs to elute until CPOT ≥ 3 and RASS > 0. The infusion rate of remifentanil was adjusted according to the CPOT score (1.5ug/kg/h is recommended, the range of adjustment is 1.5\~12μg/kg/h, and the maximum infusion rate is not more than 12μg/kg/h) until the subject's analgesic score of CPOT\<3, and the interval between the two experimental rate adjustments of the drug should be ≧5min, and the CPOT score should be performed before each adjustment of the drug. The CPOT score should be performed before each drug adjustment.
Study NCT06376890 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Red chili peppers
Description: 2.4 grams/day of powdered red chili pepper
Study NCT06376890 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Green Chili Pepper
Description: 2.4 grams/day of powdered green chili peppers
Study NCT06376890 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2.4 grams of a metabolically equivalent placebo